First American Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.74M Hold
29,567
0.21% 83
2026
Q1
$4.12M Hold
29,567
0.26% 70
2025
Q4
$3.63M Sell
29,567
-30
-0.1% -$3.65K 0.22% 79
2025
Q3
$3.29M Sell
29,597
-165
-0.6% -$18.8K 0.21% 82
2025
Q2
$3.3M Hold
29,762
0.23% 79
2025
Q1
$3.33M Hold
29,762
0.25% 77
2024
Q4
$2.75M Sell
29,762
-38
-0.1% -$3.42K 0.19% 83
2024
Q3
$2.5M Sell
29,800
-409
-1% -$31.2K 0.18% 87
2024
Q2
$2.07M Hold
30,209
0.16% 94
2024
Q1
$2.21M Hold
30,209
0.17% 96
2023
Q4
$2.45M Sell
30,209
-325
-1% -$25.3K 0.2% 91
2023
Q3
$2.29M Buy
30,534
+396
+1% +$30.5K 0.21% 92
2023
Q2
$2.32M Hold
30,138
0.2% 92
2023
Q1
$2.5M Sell
30,138
-535
-2% -$44.3K 0.23% 90
2022
Q4
$2.63M Buy
30,673
+101
+0.3% +$8K 0.25% 83
2022
Q3
$1.89M Buy
30,572
+132
+0.4% +$8.32K 0.2% 98
2022
Q2
$1.88M Sell
30,440
-234
-0.8% -$14.5K 0.19% 98
2022
Q1
$1.82M Hold
30,674
0.15% 109
2021
Q4
$2.23M Hold
30,674
0.12% 139
2021
Q3
$2.14M Sell
30,674
-740
-2% -$52K 0.12% 139
2021
Q2
$2.16M Sell
31,414
-335
-1% -$22.4K 0.13% 137
2021
Q1
$2.05M Sell
31,749
-261
-0.8% -$16.8K 0.13% 137
2020
Q4
$1.86M Sell
32,010
-15,903
-33% -$960K 0.12% 135
2020
Q3
$3.03M Sell
47,913
-20
-0% -$1.39K 0.18% 124
2020
Q2
$3.69M Hold
47,933
0.23% 110
2020
Q1
$3.58M Sell
47,933
-21,405
-31% -$1.48M 0.27% 104
2019
Q4
$4.51M Buy
+69,338
New +$4.52M 0.28% 102
2019
Q2
$4.72M Sell
69,833
-769
-1% -$50.6K 0.32% 89
2019
Q1
$4.59M Sell
70,602
-473
-0.7% -$31.4K 0.33% 88
2018
Q4
$4.45M Sell
71,075
-660
-0.9% -$46.1K 0.35% 82
2018
Q3
$5.54M Buy
+71,735
New +$5.42M 0.38% 74
2018
Q1
$5.39M Buy
71,538
+681
+1% +$54.1K 0.41% 73
2017
Q4
$5.08M Sell
70,857
-629
-0.9% -$47.8K 0.39% 76
2017
Q3
$5.79M Sell
71,486
-2,815
-4% -$215K 0.44% 71
2017
Q2
$5.26M Buy
74,301
+12,352
+20% +$822K 0.42% 71
2017
Q1
$4.21M Sell
61,949
-26,308
-30% -$1.85M 0.34% 84
2016
Q4
$6.32M Sell
88,257
-6,423
-7% -$477K 0.53% 50
2016
Q3
$7.49M Sell
94,680
-5,325
-5% -$433K 0.69% 32
2016
Q2
$8.34M Sell
100,005
-22,273
-18% -$1.98M 0.8% 28
2016
Q1
$11.2M Sell
122,278
-38,943
-24% -$3.51M 1.11% 21
2015
Q4
$16.3M Sell
161,221
-5,893
-4% -$613K 1.66% 13
2015
Q3
$16.4M Buy
167,114
+334
+0.2% +$37.1K 1.8% 10
2015
Q2
$19.5M Sell
166,780
-32,279
-16% -$3.53M 1.93% 11
2015
Q1
$19.5M Sell
199,059
-2,317
-1% -$235K 1.92% 12
2014
Q4
$19M Sell
201,376
-37,642
-16% -$3.89M 2.01% 10
2014
Q3
$25.4M Sell
239,018
-6,355
-3% -$622K 2.77% 8
2014
Q2
$20.3M Sell
245,373
-2,135
-0.9% -$166K 2.19% 10
2014
Q1
$17.5M Buy
247,508
+1,692
+0.7% +$133K 1.95% 13
2013
Q4
$18.5M Sell
245,816
-1,035
-0.4% -$72.1K 2.11% 12
2013
Q3
$15.5M Sell
246,851
-1,222
-0.5% -$73K 1.91% 12
2013
Q2
$12.7M Buy
+248,073
New +$12.9M 1.77% 14

Other funds holding GILD

First American Bank's GILD Position: Q2 2026 in Review

First American Bank held its Gilead Sciences (GILD) position steady in Q2 2026 at 29,567 shares worth $3.74M. The position accounts for 0.21% of the portfolio, ranked #83.

First American Bank first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $25.4M in Q3 2014. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • First American Bank held 29,567 shares of Gilead Sciences worth $3.74M as of Q2 2026.
  • First American Bank left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.21% of First American Bank's portfolio in Q2 2026, its #83 holding.
  • First American Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
  • First American Bank's Gilead Sciences position peaked at $25.4M in Q3 2014.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.